Potential cost-effectiveness of using a collagen-containing dressing in managing diabetic foot ulcers in the UK.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Wound Care

• Publication date

  2018-03-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.12968/jowc.2018.27.3.136PMID 29509110
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diabetic foot ulcer management in clinical practice in the UK: costs and outcomes

  2018cited by this paper
• Cost-effectiveness of using adjunctive porcine small intestine submucosa tri-layer matrix compared with standard care in managing diabetic foot ulcers in the US.

  2017cited by this paper
• Health economic burden that different wound types impose on the UK's National Health Service

  2017cited by this paper
• The health economic burden that acute and chronic wounds impose on an average clinical commissioning group/health board in the UK.

  2017cited by this paper
• Use of collagenase ointment in conjunction with negative pressure wound therapy in the care of diabetic wounds: a case series of six patients

  2015cited by this paper
• A clinical trial of Integra Template for diabetic foot ulcer treatment

  2015cited by this paper
• Health economic burden that wounds impose on the National Health Service in the UK

  2015cited by this paper
• Randomized controlled trial on collagen/oxidized regenerated cellulose/silver treatment

  2013cited by this paper
• Collagen-based wound dressings for the treatment of diabetes-related foot ulcers: a systematic review

  2013cited by this paper
• A Prospective, Single-Center, Nonblinded, Comparative, Postmarket Clinical Evaluation of a Bovine-Derived Collagen With Ionic Silver Dressing versus a Carboxymethylcellulose and Ionic Silver Dressing for the Reduction of Bioburden in Variable-Etiology, Bilateral Lower-Extremity Wounds

  2012cited by this paper
• Management of Diabetic Foot Ulcers

  2012cited by this paper
• Effect of Oxidized Regenerated Cellulose/Collagen Matrix on Proteases in Wound Exudate of Patients With Diabetic Foot Ulcers

  2011cited by this paper
• A Retrospective Analysis of the Cost-effectiveness of a Collagen/Oxidized Regenerated Cellulose Dressing in the Treatment of Neuropathic Diabetic Foot Ulcers

  2010cited by this paper
• Apligraf in the Treatment of Neuropathic Diabetic Foot Ulcers

  2009cited by this paper
• Pilot Trial of Biovance Collagen-Based Wound Covering for Diabetic Ulcers

  2009cited by this paper
• An economic evaluation of VAC therapy compared with wound dressings in the treatment of diabetic foot ulcers.

  2008cited by this paper
• Synergistic action of protease-modulating matrix and autologous growth factors in healing of diabetic foot ulcers. A prospective randomized trial.

  2007cited by this paper
• [Randomized comparative trial of a collagen/oxidized regenerated cellulose dressing in the treatment of neuropathic diabetic foot ulcers].

  2007cited by this paper
• Estudio aleatorizado y comparativo de un apósito de colágeno y celulosa oxidada regenerada en el tratamiento de úlceras neuropáticas de pie diabético

  2007cited by this paper
• Healing diabetic neuropathic foot ulcers: are we getting better?

  2005cited by this paper
• The management of hard-to-heal necrobiosis with PROMOGRAN.

  2003cited by this paper
• Cost-effectiveness of treating deep diabetic foot ulcers with Promogran in four European countries.

  2002cited by this paper
• A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers.

  2002cited by this paper
• Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial.

  2001cited by this paper
• A bilayered living skin construct (APLIGRAF®) accelerates complete closure of hard‐to‐heal venous ulcers

  1999cited by this paper
• Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human Skin Equivalent Investigators Group.

  1998cited by this paper

• Recent advancements in natural polymers-based self-healing nano-materials for wound dressing.

  2024cites this paper
• The clinical efficacy of collagen dressing on chronic wounds: A meta-analysis of 11 randomized controlled trials

  2022cites this paper
• Skin Substitutes for Adults With Diabetic Foot Ulcers and Venous Leg Ulcers: A Health Technology Assessment.

  2021cites this paper
• Potential cost‐effectiveness of using adjunctive dehydrated human amnion/chorion membrane allograft in the management of non‐healing diabetic foot ulcers in the United Kingdom

  2021cites this paper
• Cost Effectiveness of Fish Skin Grafts Versus Standard of Care on Wound Healing of Chronic Diabetic Foot Ulcers: A Retrospective Comparative Cohort Study.

  2020cites this paper
• Autologous non-cultured keratinocyte cell suspension in non-healing diabetic ulcers: A preliminary study

  2020cites this paper
• Economic evaluations considering costs and outcomes of diabetic foot ulcer infections: A systematic review

  2020influential citation
• Protease technology in wound repair

  2020cites this paper
• Dehydrated human amnion and chorion allograft versus standard of care alone in treatment of Wagner 1 diabetic foot ulcers: a trial-based health economics study

  2020cites this paper
• Collagen dressing in the treatment of diabetic foot ulcer: A prospective, randomized, placebo-controlled, single-center study.

  2019cites this paper
• Healing of wounds in lower extremities employing a non-thermal plasma

  2019cites this paper
• Natural Products as Wound Healing Agents

  2019cites this paper